EX-99.(D)(XI) 11 a07-20650_1ex99ddxi.htm EX-99.(D)(XI)

Exhibit (d)(xi)

THERAVANCE, INC.

ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON APRIL 26, 2006
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned hereby appoints Rick E Winningham and Michael W. Aguiar as proxies, each will full power of substitution, to represent and vote as designated on the reverse side, all the shares of Class A Common Stock of Theravance, Inc. held of record by the undersigned on March 1, 2006, at the Annual Meeting of Stockholders to be held at the Presidio Room, Embassy Suites Hotel, 250 Gateway Boulevard, South San Francisco, California 94080, at 1:00 p.m. local time on April 26, 2006 or any adjournment or postponement thereof.

(Continued and to be signed on next page)




ANNUAL MEETING OF STOCKHOLDERS OF

THERAVANCE, INC.

April 26, 2006

Please date, sign and mail

your proxy card in the

envelope provided as soon

as possible.

Please detach along perforated line and mail in the envelope provided.

 

 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” ALL NOMINEES AND “FOR” PROPOSAL 2. PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE x

 

1.  Election of Directors:

 

 

 

NOMINEES:

x  FOR ALL NOMINEES

o  P. Roy Vagelos, M.D.

 

o  Rick E Winningham

o  WITHHOLD AUTHORITY FOR ALL NOMINEES

o  Julian C. Baker

 

o  Jeffrey M. Drazan

o  FOR ALL EXCEPT
(See instructions below)

o  Robert V. Gunderson, Jr.

o  Arnold J. Levine, Ph.D.

 

o  Ronn C. Loewenthal

 

o  Eve E. Slater, M.D., F.A.C.C.

 

o  William H. Waltrip

 

o  George M. Whitesides, Ph.D.

 

o  William D. Young

INSTRUCTION: To withhold authority to vote for any individual nominee(s), mark “FOR ALL EXCEPT” and fill in the circle next to each nominee you wish to withhold, as shown here:  x

 

FOR

AGAINST

ABSTAIN

2.

To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Theravance, Inc. for its fiscal year ending December 31, 2006.

x

o

o

 

 

 

 

In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting.

 

 

 

 

This proxy is solicited on behalf of the Board of Directors of Theravance, Inc.  This proxy, when properly executed, will be voted in accordance with the instructions given above. If no instructions are given, this proxy will be voted “FOR” all nominees and “FOR” proposal 2.

 

To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.

o

 

SmithKline Beecham Corporation by Donald F. Parman, VP & Secretary

Signature of Stockholder

/s/ Donald F. Parman Secretary

  Date:

4/3/06

  Signature of Stockholder

 

  Date:

 

 

Note:

 

Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.